LLY
ELI LILLY
PEG ratio, current and historical analysis
- Stocks
- Healthcare
- NYSE: LLY
- PEG Ratio
ELI LILLY is trading with a PEG ratio of 0.31, based on Jun 17, 2026 data. Dividing the 39.45 PE ratio by the 128.4% earnings growth rate yields this valuation metric. Relative to the 0.41 average from the previous four quarters, the PEG ratio has decreased by 24%.
LLY PEG ratio history
Historically, ELI LILLY shows a PEG ratio averaging 6.19 across the past ten years. At 0.31, today's PE to growth ratio sits 95% below its historical average. The ten years high occurred in the Mar 2022 quarter at 60.51, reflecting maximum valuation relative to growth. The minimum was hit in the Jun 2019 quarter at 0, indicating optimal value relative to growth during that period.
ELI LILLY PEG ratio by year
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| 2025 | 0.49 | 46.73 | 95.6% |
| 2024 | 0.64 | 65.65 | 102.1% |
| 2023 | N/A | 100.16 | -16% |
| 2022 | 4.16 | 52.79 | 12.7% |
| 2021 | N/A | 44.91 | -9.8% |
| 2020 | N/A | 24.76 | -23.6% |
| 2019 | 0.08 | 14.72 | 184.4% |
| 2018 | 0.02 | 36.85 | 1,752.6% |
| 2017 | N/A | N/A | -107.3% |
| 2016 | 2.01 | 28.4 | 14.1% |
| 2015 | 20.62 | 37.12 | 1.8% |
| 2014 | N/A | 30.94 | -48.5% |
| 2013 | 0.65 | 11.78 | 18% |
| 2012 | N/A | 13.44 | -5.9% |
| 2011 | N/A | 10.66 | -14.8% |
ELI LILLY PEG ratio by quarter (TTM)
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| Mar 2026 | 0.25 | 32.63 | 128.4% |
| Dec 2025 | 0.49 | 46.73 | 95.6% |
| Sep 2025 | 0.31 | 37.24 | 120.6% |
| Jun 2025 | 0.58 | 50.78 | 88.3% |
| Mar 2025 | 0.83 | 66.93 | 80.9% |
| Dec 2024 | 0.64 | 65.65 | 102.1% |
| Sep 2024 | 1.41 | 95.36 | 67.7% |
| Jun 2024 | 8.55 | 111.09 | 13% |
| Mar 2024 | 14.08 | 114.07 | 8.1% |
| Dec 2023 | N/A | 100.16 | -16% |
| Sep 2023 | N/A | 96.95 | -17.1% |
| Jun 2023 | 4.46 | 65.05 | 14.6% |
| Mar 2023 | N/A | 54.42 | -6.7% |
| Dec 2022 | 4.16 | 52.79 | 12.7% |
| Sep 2022 | 28.48 | 48.41 | 1.7% |
LLY average PEG ratio chart
Measured against past performance, LLY's PEG ratio is below the 3, 5 and 10-year averages.
PEG comparison
ELI LILLY's PEG of 0.31 is below the Healthcare sector, the industry and its peers average. Compared to its Healthcare sector average of 0.56, ELI LILLY's PEG is 45% lower.
LLY EPS growth
LLY Price vs fair value
LLY PEG vs peers
LLY has a PEG ratio below that of peer stocks NVS and AZN. At 0.31, ELI LILLY's PEG ratio stands lower than the peer group average of 1.09.
| Stock name | PEG ratio | Market cap |
|---|---|---|
| LLY ELI LILLY & Co | 0.31 | $1.05T |
| BMY Bristol Myers Squibb Co | 0.47 | $112.89B |
| AMGN Amgen Inc | 0.76 | $184.4B |
| AZN Astrazeneca plc | 0.78 | $275.55B |
| NVS Novartis AG | 2.34 | $287.89B |
| MRK Merck & Co Inc | N/A | $285.12B |
| JNJ Johnson & Johnson | N/A | $563.77B |
| PFE Pfizer Inc | N/A | $147.73B |
| ABBV AbbVie Inc | N/A | $390.87B |
Frequently asked questions
What is ELI LILLY's PEG ratio?
Based on Jun 17, 2026 data, LLY carries a PEG ratio of 0.31.
What is the 3-year average PEG ratio for ELI LILLY (LLY)?
Over the last 3 years, LLY's PEG ratio has settled near 3.16.
What is the 5-year average PEG ratio for ELI LILLY (LLY)?
Over the last 5 years, LLY's PEG ratio has settled near 8.95.
What is the highest PEG ratio for LLY?
The Mar 2022 quarter marked the ten years high at 60.51 for LLY's PEG ratio.
How does the current PEG ratio for LLY compare to its historical average?
Compared to the 10-year average, LLY's PEG ratio is 95% lower.
Why is ELI LILLY's PEG ratio so low?
The 0.31 PEG ratio for LLY reflects strong earnings growth outpacing the current valuation.
How is LLY's PEG ratio calculated (ELI LILLY PEG ratio formula)?
The PEG ratio comes from taking PE and dividing by the rate at which earnings are growing (YoY TTM). As of Jun 17, 2026, ELI LILLY has a P/E ratio of 39.45. Earnings grew at 128.4% over the TTM period ending Mar 2026. Applying the formula, this produces a price to earnings growth ratio of 0.31. PEG RATIO(0.31) = PE RATIO(39.45) / EPS GROWTH(128.4%)
All PEG ratio stats are based on quarterly TTM periods, unless otherwise specified.